Maintenance Treatment
460 articles
Going the Extra Mile for Treatment—or Not?
Should you go to a larger cancer center or stay closer to home at a smaller hospital? Learn about the pros and cons of each option.
Novel Drug Therapy Kills Pancreatic Cancer Cells by Reducing Levels of Antioxidants
New research finds that reducing antioxidants can help kill pancreatic cancer cells, suggesting a new direction for treatment.
Potential Therapy Takes a Two-Prong Attack on Pancreatic Cancer
With a focus on targeting cell metabolism, Dr. Anup Kasi leads a clinical trial of a new agent in combination with gemcitabine.
Privacy Policy
At Let’s Win, we take your privacy seriously. Please read the following Privacy Policy (the “Privacy Policy”) in order to learn more about our policies, practices, and procedures regarding our website, including the personally identifiable information that we may collect from you, and the uses that we may make of your information. This Privacy Policy […]
Low-Dose Continuous Chemotherapy as Part of a New Combination of Drugs
A clinical trial uses a new immunotherapy drug in combination with standard chemotherapy drugs in metronomic therapy to treat metastatic pancreatic cancer.
For Pancreatic Cancer Patients, Pain Control Through Targeted Radiotherapy
Dr. Yaacov Lawrence is using celiac plexus radiotherapy in a clinical trials to target a source of pain for pancreatic cancer patients.
This Is What It’s Like To Live With Pancreatic Cancer
Anne Glauber recounts her treatment for pancreatic cancer for Prevention magazine and offers insights on embracing each day and living it to its fullest.
Platform Trial Increases Efficiency in Studying Immunotherapy
Dr. Elizabeth Jaffee is betting that three types of immunotherapy will rev up the immune system and make chemotherapy more effective in a platform trial.
Multicenter Trial Focuses on Neoadjuvant Treatment for Borderline Resectable and Locally Advanced Disease
Dr. David Ryan outlines a new trial for pre-surgical pancreatic cancer treatment combining a blood pressure drug, immunotherapy, standard care and SBRT.